U.S. Online Retail and Ecommerce Stock News

Vuzix (VUZI) has put out its latest FY 2025 numbers with Q3 revenue of about US$1.2 million and a basic EPS loss of US$0.10, alongside a trailing 12 month EPS loss of roughly US$0.49 on revenue of US$5.3 million. Over recent quarters the company has seen revenue move between about US$1.1 million and US$1.6 million while quarterly basic EPS losses have ranged from roughly US$0.10 to US$0.16. As a result, investors may focus less on top line swings and more on how much cash is being burned to...

Marriott International (NasdaqGS:MAR) has launched its "Where Gameday Checks In" campaign tied to NCAA March Madness and FIFA events. The campaign features high profile athletes and aims to connect Marriott Bonvoy more closely with U.S. sports culture and major global tournaments. In parallel, the company is renovating resorts and adding new all inclusive experiences in Mexico, including properties in Riviera Nayarit and Puerto Vallarta. For you as an investor, this update sits at the...

Why Schwab’s surging client activity and new APIs matter for investors Charles Schwab (SCHW) is back in focus after its Schwab Trading Activity Index posted the largest monthly gain since late 2020. This comes alongside new API tools that simplify advisory account openings and signal deeper digital engagement. See our latest analysis for Charles Schwab. Schwab’s recent client activity and API rollout come after a period where the 1 year total shareholder return of 22.17% contrasts with a year...

Oncology Institute (TOI) closed out FY 2025 with Q4 revenue of US$142.0 million and a basic EPS loss of US$0.07, while trailing twelve month figures show revenue of US$502.7 million and a net loss of US$60.6 million. The company has seen quarterly revenue move from US$100.3 million in Q4 2024 to US$142.0 million in Q4 2025, with basic EPS losses ranging from US$0.21 in Q1 2025 to US$0.07 in Q4, presenting a picture in which top line scale is increasing while margins remain clearly...

Ulta Beauty (ULTA) has capped FY 2026 with fourth quarter revenue of US$3.9b and basic EPS of US$8.05, alongside net income of US$356.7m, while full year trailing revenue sits at US$12.4b and EPS at US$25.72. The company has seen quarterly revenue move from US$3.5b and EPS of US$8.50 in Q4 FY 2025 to US$3.9b and EPS of US$8.05 in Q4 FY 2026, with comparable sales for the latest quarter at 5.8% and trailing twelve month same store sales growth at 5.4%. With net income over the last twelve...

Cal-Maine Foods, Inc. recently highlighted its position as the largest U.S. egg producer and scheduled the release of its fiscal 2026 third-quarter results, alongside a management webcast that has now taken place. At the same time, a sharp contrast has emerged between the company’s historically strong revenue growth and analysts’ expectations for a very large revenue decline over the next year. We’ll now examine how concerns about a very large potential revenue drop interact with Cal-Maine...

AMREP (AXR) has released its Q3 2026 scorecard, with Q2 fiscal 2026 revenue of US$9.4 million and basic EPS of US$0.22, alongside trailing twelve month revenue of US$45.9 million and EPS of US$1.97 as investors weigh the latest move in margins. Over the past six reported quarters, the company has seen quarterly revenue range between US$7.5 million and US$19.1 million, while basic EPS has moved between US$0.13 and US$0.88. This provides a clear data trail on how the business has been...

KinderCare Learning Companies (KLC) has put up a mixed set of FY 2025 numbers, with third quarter revenue at US$676.8 million and basic EPS of US$0.04, against a trailing twelve month picture that still shows a loss with EPS of US$0.59 on revenue of about US$2.7 billion. Over recent quarters the company has seen revenue move between US$668.2 million and US$700.1 million, while basic EPS ranged from US$0.18 to US$0.33. The latest print now sits at the lower end of that earnings range, so...

Atlanticus Holdings (ATLC) has wrapped up FY 2025 with Q4 revenue of US$175.8 million and basic EPS of US$2.18, alongside trailing 12 month revenue of US$557.2 million and EPS of US$7.40 that frame the scale of its recent earnings power. Over the past six quarters, the company has seen revenue move from US$100.1 million in Q3 2024 to US$175.8 million in Q4 2025, with quarterly EPS ranging between about US$1.50 and US$2.18. This sets up a results picture where healthy top line levels sit...

If you are wondering whether TechnipFMC's current share price still offers value or if you might be late to the story, you are in the right place. The stock last closed at US$63.03, with returns of 0.0% over 7 days, 2.0% over 30 days, 33.2% year to date, 132.8% over 1 year, 420.0% over 3 years and a very large 5 year return that is around 7x the starting point. Recent news around TechnipFMC has focused on its role as an energy services and technology provider, with attention on how its...

PayPay (PAYP) has just come to market with a high profile US$879.8m IPO of American Depositary Shares, followed immediately by a roughly US$199.0m shelf registration tied to an ESOP related offering. See our latest analysis for PayPay. Coming straight after a strong first trading session and the ESOP related shelf registration, PayPay’s 1 day share price return of 16.41% and year to date share price return of 32.12% suggest early momentum and rising risk appetite around the stock’s story. If...

Mach Natural Resources (MNR) closed out FY 2025 with fourth quarter revenue of US$460.8 million and basic EPS of US$0.43, while trailing twelve month revenue sat at US$1.2 billion and EPS at US$1.09. The company has seen revenue move from US$942.8 million and EPS of US$1.90 on a trailing basis in Q4 2024 to US$1.2 billion and EPS of US$1.09 in the latest period, giving investors a clear view of how the top line and EPS have shifted over the past year. With net profit margins easing from 19.6%...

In early 2026, multiple law firms launched or expanded securities class action lawsuits alleging Boston Scientific misled investors about the performance and sustainability of growth in its U.S. Electrophysiology segment, following weaker-than-expected 2025 results and cautious 2026 guidance. At the same time, Boston Scientific moved ahead with clinical expansion efforts, planning a new China registry for its ENROUTE neuroprotection system and Carotid WALLSTENT to build real-world evidence...

Sunbelt Rentals Holdings (SUNB) has put fresh numbers on the board for Q3 2026, reporting revenue of US$2.6b and basic EPS of US$0.69, with net income excluding extra items at US$290m. Over recent quarters the company has seen revenue move from US$2.6b in Q3 2025 to US$2.5b in Q4 2025, then to US$2.8b in Q1 2026 and US$3.0b in Q2 2026. Quarterly EPS ranged from US$0.71 to US$1.11 over that stretch, setting up Q3’s EPS of US$0.69 in a context of shifting profitability. With net profit margin...

Americold Realty Trust overview after recent performance Americold Realty Trust (COLD) has drawn investor attention after a period of weak share performance, with the stock showing negative returns over the past year, past 3 months, and month, alongside a reported net loss. See our latest analysis for Americold Realty Trust. The recent weakness has been persistent, with a 7 day share price return of 11.03% and a year to date share price return of 13.99%, while the 1 year total shareholder...

StoneX Group (NasdaqGS:SNEX) has elected John Radziwill as Chairman of the Board. Sean M. O'Connor has been appointed Executive Vice-Chairman following the latest shareholder and board meetings. These board-level changes follow the company’s annual governance cycle and signal a refreshed leadership structure. StoneX Group operates as a global financial services firm connecting clients to a wide range of markets, from commodities and foreign exchange to securities and clearing. For...

Hallador Energy (HNRG) just closed out FY 2025 with fourth quarter revenue of US$101.9 million and a small net loss of US$0.24 million, translating to a near flat basic EPS of a US$0.01 loss, against a trailing twelve month picture that shows revenue of US$469.5 million and net income of US$41.9 million, or basic EPS of US$0.98. Over recent quarters, revenue has moved from US$105.2 million in Q3 2024 to US$117.8 million in Q1 2025, US$102.9 million in Q2, US$146.8 million in Q3 and US$101.9...

If you are trying to figure out whether Trex Company is genuinely good value or just looks cheap after a weak run, this article is for you. The share price closed at US$37.49, with a 0.1% decline over the last 7 days, a 14.9% decline over 30 days, a 4.6% gain year to date, and a 34.0% decline over 1 year alongside a 19.7% decline over 3 years and a 58.5% decline over 5 years. These moves have put valuation questions front and center as investors reassess what they are willing to pay for Trex...

If you are wondering whether Main Street Capital's current share price offers good value or not, you are not alone. Many income focused investors are asking the same question right now. The stock most recently closed at US$54.89, with returns of 4.8% over 1 year but declines of 4.3% over 7 days, 10.9% over 30 days and 11.1% year to date. This may be reshaping how investors think about its risk and return profile. Recent company updates and sector commentary have kept Main Street Capital on...

Tonix Pharmaceuticals Holding (TNXP) just closed out FY 2025 with fourth quarter revenue of US$5.39 million, Basic EPS of a US$3.98 loss, and a net loss excluding extra items of US$46.91 million, putting fresh numbers around a business that is still firmly in investment mode. The company has seen quarterly revenue move from US$2.58 million and Basic EPS of a US$9.77 loss in Q4 2024 to US$5.39 million and Basic EPS of a US$3.98 loss in Q4 2025, giving investors a clearer view of how sales and...

Citizens (CIA) closed out FY 2025 with fourth quarter revenue of US$72.1 million and basic EPS of US$0.14, alongside net income of US$7.3 million, giving investors a fresh look at how its underwriting and fee streams are translating into bottom line results. The company has seen quarterly revenue move from US$63.5 million in Q4 2024 to US$72.1 million in Q4 2025, with basic EPS shifting from US$0.07 to US$0.14 over the same period. Trailing 12 month EPS across recent quarters has ranged from...

Vaxart (VXRT) has reported another loss making quarter, with Q3 FY 2025 revenue of about US$72.4 million and a basic EPS loss of US$0.04, alongside trailing twelve month revenue of roughly US$148.2 million and a basic EPS loss of US$0.22. Over recent periods, the company has seen quarterly revenue move from US$4.9 million in Q3 FY 2024 to US$15.2 million in Q4 FY 2024, then to US$20.9 million in Q1 FY 2025 and US$39.7 million in Q2 FY 2025. Basic EPS losses have ranged from US$0.09 in Q2 FY...

Why ASA Gold and Precious Metals (ASA) is back on growth investors’ radar ASA Gold and Precious Metals (ASA) has drawn fresh attention after being flagged as a potential CANSLIM growth name, supported by strong quarterly and annual earnings metrics, as well as a balance sheet with no debt. See our latest analysis for ASA Gold and Precious Metals. Even after a recent 7 day share price return of around an 11% decline and a 30 day share price return of about a 10% decline from the latest close...

Cadre Holdings: Recent Moves and Context for Investors Cadre Holdings (CDRE) has been under pressure recently, with the stock showing negative returns over the past week, month, and past 3 months. This may prompt investors to reassess expectations and risk tolerance. See our latest analysis for Cadre Holdings. Despite the recent pressure, the 1-year total shareholder return of a 5.1% decline contrasts with a 72.1% gain over three years. This suggests that short term momentum has faded while...